miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer (Q39041981)

8 September 2017

miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer (English)

1 reference

8 September 2017

1 reference

Zhiqin Tan

1

1 reference

8 September 2017

Hao Jiang

2

1 reference

8 September 2017

Youhua Wu

3

1 reference

8 September 2017

Liming Xie

4

1 reference

8 September 2017

Wenxiang Dai

5

1 reference

8 September 2017

Hailin Tang

6

1 reference

8 September 2017

Sanyuan Tang

7

1 reference

8 September 2017

25 October 2013

1 reference

Molecular and Cellular Biochemistry

8 September 2017

1 reference

8 September 2017

386

1 reference

8 September 2017

1-2

1 reference

8 September 2017

223-231

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-013-1860-y

8 September 2017

0 references

cites work

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNAs and cancer: short RNAs go a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNA in cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

Metastamir: the field of metastasis-regulatory microRNA is spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNAs: novel biomarkers for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

The miR-183/96/182 cluster regulates oxidative apoptosis and sensitizes cells to chemotherapy in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

Survival prediction of gastric cancer by a seven-microRNA signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

Lymph nodes and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

Clinical significance of miR-146a in gastric cancer cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

miR-429 modulates the expression of c-myc in human gastric carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

Autoregulatory suppression of c-Myc by miR-185-3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1860-Y

21 January 2018

1 reference

12 December 2020

miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.

1 reference

PubMed

12 December 2020

miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer.

1 reference

PubMed

12 December 2020

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine

1 reference

PubMed

12 December 2020

10.1007/S11010-013-1860-Y

Identifiers

DOI

1 reference

8 September 2017

1 reference